Join Virginia Bio CEO, John Newby, for an engaging conversation on the latest developments in Virginia’s biotech ecosystem. This quarterly chat is an opportunity to connect, ask questions, and gain insights into the industry’s growth, challenges, and opportunities.
This conversation will spotlight Dr. Michael Salgaller, who leads the Technology Analysis and Marketing Unit within the National Cancer Institute’s Technology Transfer Office. With more than 20 years of experience spanning science, business, and investment, Dr. Salgaller supports the advancement and commercialization of innovative life science technologies.